Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Granules India Limited is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 0.000000
forwardPE 19.964533
debtToEquity 45.369000
earningsGrowth 0.276000
revenueGrowth 0.220000
grossMargins 0.618960
operatingMargins 0.169010
trailingEps 22.460000
forwardEps 30.005710

GRANULES's Forward PE ratio is favorable, indicating that the stock price is well-positioned in relation to its earnings. It is not overpriced, leaving room for growth, which makes it a solid option for investors seeking both stability and future appreciation.
GRANULES's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
GRANULES's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that GRANULES's financial performance will improve in the current financial year.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

GRANULES's price projections have gradually risen, indicating growing confidence in the company's prospects. This upward trend suggests that analysts expect GRANULES to continue performing well in the future.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


GRANULES has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view GRANULES as a stable option to park their money and potentially benefit from the company's continued growth and profitability.